Home » Authors » Cormac Sheridan

Cormac Sheridan

Articles

ARTICLES

Medicon Valley Developing R&D Capabilities, Attracting Attention

Nov. 20, 2002

By Cormac Sheridan

Medicon Valley, the transnational region spanning the greater Copenhagen area in Denmark and the Sk ne region in southern Sweden, is laying claim to global leadership in diabetes R&D capability. (BioWorld International)

Prokaria Fishing For Products In The Hot Springs Of Iceland

Nov. 20, 2002

By Cormac Sheridan

Medicon Valley Developing R&D Capabilities, Attracting Attention

Nov. 20, 2002

By Cormac Sheridan

Medicon Valley, the transnational region spanning the greater Copenhagen area in Denmark and the Sk ne region in southern Sweden, is laying claim to global leadership in diabetes R&D capability. (BioWorld International)

Medicon Valley Developing R&D Capabilities In Four Key Areas

Nov. 18, 2002

By Cormac Sheridan

Medicon Valley Developing R&D Capabilities In Four Key Areas

Nov. 18, 2002

By Cormac Sheridan

Meridian, Biotrin Call Off Merger Talks, Decline To Provide Details

Nov. 13, 2002

By Cormac Sheridan

Meridian, Biotrin Call Off Merger Talks, Decline To Provide Details

Nov. 13, 2002

By Cormac Sheridan

NeuroSearch, Boehringer Ingelheim Move Alzheimer's Drug To Phase IIb

Nov. 6, 2002

By Cormac Sheridan

Advances In Irish Biotech Efforts On Display At Meeting Next Week

Nov. 6, 2002

By Cormac Sheridan

NeuroSearch, Boehringer Ingelheim Move Alzheimer's Drug To Phase IIb

Nov. 6, 2002

By Cormac Sheridan

View All Articles by Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...